Barinthus Biotherapeutics (BRNS) Short-term Investments (2024 - 2026)

Barinthus Biotherapeutics has reported Short-term Investments for 3 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 8.9% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 8.9% YoY), and the FY2025 full-year result was $1.4 million, down 19.68% from the prior year.
• Short-term Investments for Q1 2026 stood at $1.3 million, down from $1.4 million in the prior quarter.
• The five-year high for Short-term Investments was $1.7 million in Q4 2024, with the low at $1.3 million in Q1 2026.
• Historically, Short-term Investments has averaged $1.5 million across 3 years, with a median of $1.4 million in 2025.
• Annual changes were most pronounced in 2025 — Short-term Investments slipped 19.68% — and 2026, when it retreated 8.9%.
• Barinthus Biotherapeutics' Short-term Investments stood at $1.7 million in 2024, then decreased by 19.68% to $1.4 million in 2025, then fell by 4.66% to $1.3 million in 2026.
• The last three Short-term Investments figures came in at $1.3 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.